Prof. Dr. Michael SiewekePerson
Person
Identification Numbers
| ORCID | 
0000-0002-3228-9537 |
|---|---|
| Scopus author ID | 6603753443 |
Related content
- Research output
- Prizes
- Press/Media
M-CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation
Kandalla, P. K., Subburayalu, J., Cocita, C., de Laval, B., Tomasello, E., Iacono, J., Nitsche, J., & 12 othersCanali, M. M., Cathou, W., Bessou, G., Mossadegh-Keller, N., Huber, C., Mouchiroud, G., Bourette, R. P., Grasset, M. F., Bornhäuser, M., Sarrazin, S., Dalod, M. & Sieweke, M. H., 8 Nov 2023, In: EMBO molecular medicine. 15, 11, e17694.Research output: Contribution to journal › Research article › Contributed › peer-review
La danse entre Brucella et les cellules souches hématopoïétiques
Arce-Gorvel, V., Hysenaj, L., de Laval, B., Sieweke, M. H., Sarrazin, S. & Gorvel, J-P., Nov 2023, In: Medecine sciences : M/S. 39, 11, p. 822-824 3 p.Research output: Contribution to journal › Letter › Contributed › peer-review
Isolation, Ex Vivo Expansion, and Lentiviral Transduction of Alveolar Macrophages
Busch, C. J-L., Subramanian, S., Linares, J., Favret, J., Yuda, R. A. A. & Sieweke, M. H., 29 Aug 2023, Tissue-Resident Macrophages: Methods and Protocols. Springer Nature, p. 231-251 21 p. (Methods in Molecular Biology (MIMB; Vol. 2713), Vol. 2713).Research output: Contribution to book/conference proceedings/anthology/report › Chapter in book/anthology/report › Contributed › peer-review
CD150-dependent hematopoietic stem cell sensing of Brucella instructs myeloid commitment
Hysenaj, L., de Laval, B., Arce-Gorvel, V., Bosilkovski, M., González-Espinoza, G., Debroas, G., Sieweke, M. H., & 2 othersSarrazin, S. & Gorvel, J-P., 3 Jul 2023, In: The Journal of experimental medicine. 220 (2023), 7, 15 p., e20210567.Research output: Contribution to journal › Research article › Contributed › peer-review
PLACENTAL MACROPHAGES FOR CELL THERAPY
Sieweke, M. & Kandalla, P. K., 1 Jun 2023, IPC (International Patent Classification) C12N 5/ 0786 A I, Patent No. WO2023094436, Priority date 26 Nov 2021, Priority No. EP20210210741Research output: Intellectual Property › Patent application/Patent
4th place in the Science4Life Venture Cup "businessplan phase"
Sieweke, M. (Recipient), Englmeier, L. (Recipient), Fuchs, A. (Recipient) & Bornhäuser, M. (Recipient), 27 Jun 2023
Prize: Innovation/transfer prize
One of the ten winning teams in the Science4Life Venture Cup "concept phase"
Sieweke, M. (Recipient), Englmeier, L. (Recipient), Fuchs, A. (Recipient) & Bornhäuser, M. (Recipient), 14 Mar 2023
Prize: Innovation/transfer prize
Alexander-von-Humboldt Professorship
Sieweke, M. (Recipient), 1 Apr 2018
Prize: Fellow/scholarship › Professorship
W3 Professorship at the TU Dresden
Sieweke, M. (Recipient), 2018
Prize: Fellow/scholarship › Professorship
Fourth Place for Makrophagen 2.0 at the Science4Life Start-up Competition
Fuchs, A., Sieweke, M. & Englmeier, L.
29 Sept 2023
1 Media contribution
Press/Media
Start-up Project Makrophagen 2.0 One of the Winners of The Concept Phase of the Science4Life Venture Cup
Fuchs, A., Sieweke, M. & Englmeier, L.
22 Mar 2023
1 Media contribution
Press/Media
From Lab to Business: CRTD Researchers receive BMBF GO-Bio Initial Funding
Fuchs, A., Sieweke, M. & Englmeier, L.
26 Aug 2022
1 Media contribution
Press/Media